相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones
Suzanne A. Nasser et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Leukocyte matrix metalloproteinase and tissue inhibitor gene expression patterns in children with primary hypertension
Joanna B. Trojanek et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling Transcriptional Regulation by SOX and HIF-2α
Xiaoguang Sun et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
Tania Romacho et al.
SCIENTIFIC REPORTS (2020)
Visfatin Increases VEGF-Dependent Angiogenesis of Endothelial Progenitor Cells during Osteoarthritis Progression
Chun-Hao Tsai et al.
CELLS (2020)
Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets
Manal Muin Fardoun et al.
CLINICAL SCIENCE (2020)
Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
Meifan Zheng et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Visfatin increases ICAM-1 expression and monocyte adhesion in human osteoarthritis synovial fibroblasts by reducing miR-320a expression
Yat-Yin Law et al.
AGING-US (2020)
A collagen Vα1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site
Tao Jia et al.
MATRIX BIOLOGY (2020)
The up-regulation of markers of adipose tissue fibrosis by visfatin in pre-adipocytes as well as obese children and adolescents
Samira Ezzati-Mobaser et al.
CYTOKINE (2020)
Reactive Oxygen Species: Modulators of Phenotypic Switch of Vascular Smooth Muscle Cells
Adnan Badran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
Ibrahim AlZaim et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance
Maria Teresa Pallotta et al.
JOURNAL OF CELL SCIENCE (2020)
Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders
Ali Dakroub et al.
CELLS (2020)
MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway
Sara Cheleschi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of the adipocytokines vaspin and visfatin in vascular endothelial function and insulin resistance in obese children
Chunyan Yin et al.
BMC ENDOCRINE DISORDERS (2019)
NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia
Daniela A. Pereira et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)
The role of adipose tissue in cardiovascular health and disease
Evangelos K. Oikonomou et al.
NATURE REVIEWS CARDIOLOGY (2019)
Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice
Yuan-yuan Kong et al.
ACTA PHARMACOLOGICA SINICA (2019)
CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway
Dane Parker
CYTOKINE (2018)
Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension
Isola A. M. Brown et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Visfatin Promotes Wound Healing through the Activation of ERK1/2 and JNK1/2 Pathway
Byung-Cheol Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome
Kalliopi Dambala et al.
GYNECOLOGICAL ENDOCRINOLOGY (2017)
p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation
Nikhlesh K. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The immunology of atherosclerosis
Anton Gistera et al.
NATURE REVIEWS NEPHROLOGY (2017)
Angiogenesis in the atherosclerotic plaque
Caroline Camare et al.
REDOX BIOLOGY (2017)
The role of Visfatin in atherosclerotic peripheral arterial obstructive disease
Matthaios G. Pitoulias et al.
CYTOKINE (2017)
MicroRNA-155 Promotes the Directional Migration of Resident Smooth Muscle Progenitor Cells by Regulating Monocyte Chemoattractant Protein 1 in Transplant Arteriosclerosis
Yuan Sun et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases
Guanghai Wang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
Teresa Auguet et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice
Bo Li et al.
PLOS ONE (2016)
Interleukin-6 Stimulates Defective Angiogenesis
Ganga Gopinathan et al.
CANCER RESEARCH (2015)
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature
Elena I. Deryugina et al.
MATRIX BIOLOGY (2015)
Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome
Mitra Nourbakhsh et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
V. A. Belo et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Stimulation of MMP-1 and CCL2 by NAMPT in PDL Cells
Marjan Nokhbehsaim et al.
MEDIATORS OF INFLAMMATION (2013)
Pre-B cell colony enhancing factor (PBEF/NAMPT/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion
J. M. Astern et al.
PLACENTA (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Visfatin May Be a Novel Marker for Identifying Stages of Essential Hypertension in Advanced Age Patients
Fahri Gunes et al.
INTERNAL MEDICINE (2012)
Adipose tissue: friend or foe?
Mohamed Hassan et al.
NATURE REVIEWS CARDIOLOGY (2012)
Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis
Ken Kayakabe et al.
RHEUMATOLOGY (2012)
Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway
Joo-Won Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis
Yun-Hee Bae et al.
CARDIOVASCULAR RESEARCH (2011)
Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway
Yuqi Fan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
What's new in our understanding of the role of adipokines in rheumatic diseases?
Rodolfo Gomez et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway
A. A. Wani et al.
ONCOGENE (2011)
The CD40-CD40L Pathway Contributes to the Proinflammatory Function of Intestinal Epithelial Cells in Inflammatory Bowel Disease
Frauke Borcherding et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: Implications for atherogenesis
Giovanni Barillari et al.
ATHEROSCLEROSIS (2010)
Effects of Visfatin on Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts
X-Y. Yu et al.
HORMONE AND METABOLIC RESEARCH (2010)
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Ye-Rang Yun et al.
Journal of Tissue Engineering (2010)
Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis
Fina Lovren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: Role in visfatin-induced angiogenesis
Raghu Adya et al.
ATHEROSCLEROSIS (2009)
Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis
Yun-Hee Bae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis
Jee-Young Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-κB pathway
W-J Lee et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis
Anna Nolan et al.
PLOS ONE (2009)
A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT
Emmanuel S. Burgos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
Su-Ryun Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Nuclear factor-kappa B induction by visfatin in human vascular endothelial cells - Its role in MMP-2/9 production and activation
Raghu Adya et al.
DIABETES CARE (2008)
Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women
Ji A. Seo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism
Yankun Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FGF-1-induced matrix metal loproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-κB and activating protein-1
Gina Lunqu et al.
MOLECULAR CARCINOGENESIS (2008)
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Raghu Adya et al.
CARDIOVASCULAR RESEARCH (2008)
Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro
Yongfeng Fan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Kenji Oki et al.
CLINICAL ENDOCRINOLOGY (2007)
Pre-B cell colony-enhancing Factor/Visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities
Fabia Brentano et al.
ARTHRITIS AND RHEUMATISM (2007)
Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cδ pathways in human adult articular chondrocytes
Hee-Jeong Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians
Sreedharan Sandeep et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
Jonas Axelsson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension
T. Dogru et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease
Iris Shai et al.
OBESITY (2006)
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization - Critical role of the inflammatory/arteriogenic pathway
Takaaki Fujii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Serum visfatin increases with progressive β-cell deterioration
Abel Lopez-Bermejo et al.
DIABETES (2006)
Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866
Mun-Kyoung Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets
Florencia M. Barbe-Tuana et al.
DIABETES (2006)
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
Tao Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding
DG Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression
SI Zittermann et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
J Berndt et al.
DIABETES (2005)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
M Presta et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury
SQ Ye et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A
KH Hong et al.
BLOOD (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans
JN Fain et al.
ENDOCRINOLOGY (2004)
IκB kinases:: key regulators of the NF-κB pathway
Y Yamamoto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Vascular endothelial growth factor and angiogenesis
A Hoeben et al.
PHARMACOLOGICAL REVIEWS (2004)
Chemokines in the pathogenesis of vascular disease
IF Charo et al.
CIRCULATION RESEARCH (2004)
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
LH Wei et al.
ONCOGENE (2003)
Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF 2-microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and-2 (ERK-1/2)
G Pintucci et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
NF-κB regulation in the immune system
QT Li et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury
WJ Wang et al.
CIRCULATION (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Circulating cell adhesion molecules and death in patients with coronary artery disease
S Blankenberg et al.
CIRCULATION (2001)
NF-κB signaling pathways in mammalian and insect innate immunity
N Silverman et al.
GENES & DEVELOPMENT (2001)
Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
EEJM Creemers et al.
CIRCULATION RESEARCH (2001)
Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules
NT Mulvihill et al.
HEART (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Soluble adhesion molecules in preclinical type 1 diabetes
A Toivonen et al.
PEDIATRIC RESEARCH (2001)
Therapeutic potential of inhibition of the NF-kappa B pathway in the treatment of inflammation and cancer
Y Yamamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis
KP Claffey et al.
LABORATORY INVESTIGATION (2001)
Somatic gene therapy in the cardiovascular system
I Baumgartner et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
VEGF regulates cell behavior during vasculogenesis
CJ Drake et al.
DEVELOPMENTAL BIOLOGY (2000)
Fibroblast growth factor-2
MA Nugent et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
分享论文
